Star Bulk (SBLK) Extends Share Repurchase Plan

ATHENS, GREECE — (Marketwire) — 01/23/12 — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (NASDAQ: SBLK), a global shipping company focusing on the transportation of drybulk cargoes, today announced that its Board of Directors approved the extension of the Company’s Share Repurchase Plan, which has been in place since 2010, to December 31, 2012.

The plan calls for the repurchases of Common Stock for up to $30 million to be made in open market or privately negotiated transactions in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, subject to market and business conditions, applicable legal requirements and other factors. The plan calls for the repurchased shares to be retired as soon as practicable following the repurchase. The plan does not obligate the Company to purchase any particular number of shares, and may be suspended at any time at the Company’s discretion. Any purchases under the plan are made at the discretion of the Company. The Company has made purchases under the plan and expects to report the aggregate number of shares purchased and the average price per share paid on a quarterly basis.

About Star Bulk

Star Bulk is a global shipping company providing worldwide seaborne transportation solutions in the dry bulk sector. Star Bulk’s vessels transport major bulks, which include iron ore, coal and grain and minor bulks such as bauxite, fertilizers and steel products. Star Bulk was incorporated in the Marshall Islands on December 13, 2006 and maintains executive offices in Athens, Greece. Its common stock trades on the Nasdaq Global Market under the symbol “SBLK.” Currently, Star Bulk has an operating fleet of fifteen dry bulk carriers, consisting of seven Capesize, and eight Supramax dry bulk vessels with a combined cargo carrying capacity of 1,625,943 deadweight tons. The average age of our current operating fleet is 10.6 years.

Forward-Looking Statements
Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.

The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking statements.

The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, examination by the Company’s management of historical operating trends, data contained in its records and other data available from third parties. Although the Company believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond the Company’s control, the Company cannot assure you that it will achieve or accomplish these expectations, beliefs or projections.

In addition to these important factors, other important factors that, in the Company’s view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for dry bulk shipping capacity, changes in the Company’s operating expenses, including bunker prices, drydocking and insurance costs, the market for the Company’s vessels, availability of financing and refinancing, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other factors. Please see our filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.

Contacts:
Company:
Simos Spyrou
CFO
Star Bulk Carriers Corp.
c/o Star Bulk Management Inc.
40 Ag. Konstantinou Av.
Maroussi 15124
Athens, Greece
www.starbulk.com

Investor Relations / Financial Media:
Nicolas Bornozis
President
Capital Link, Inc.
230 Park Avenue, Suite 1536
New York, NY 10169
Tel. (212) 661-7566
E-mail: starbulk@capitallink.com
www.capitallink.com

Tanzanian Royalty (TRX) Reports More Positive Results from Phase 2 Drilling Program in Footwall Zone

South Surrey, British Columbia CANADA, January 23, 2012 /FSC/ – Tanzanian Royalty Exploration Corp (TNX – TSX, TRX – NYSE Amex),is pleased to announce the receipt of further positive assay results from the ongoing Reverse Circulation (RC) drilling program in the Footwall Zone at the Company’s Buckreef Project in the Lake Victoria Goldfields of Tanzania.

The latest results include values that are among the best reported to date by any operator at Buckreef, notes Joseph K. Kahama, Chairman and Chief Operating Officer (Tanzania). Drill-hole BMRC512 returned 3.0m averaging 1.29 g/t gold from 38m; BMRC523 included 6.0m averaging 2.67g/t from 13m; BMRC536 returned 5.0m averaging 2.62g/t from 60m; BMRC537 returned 6.0m averaging 4.87g/t from 76m while BMRC538 returned 6.0m averaging 1.63g/t from 37m. True widths are estimated to be 60% of the apparent widths. The RC drilling program has so far seen the completion of 29 RC holes aggregating 1,183metres.

The Main mineralized shear zone at Buckreef includes the Buckreef Main Zone, Buckreef North Zone and Buckreef South Zone which are constrained between two cross-cutting faults. Buckreef Footwall and Hanging wall zones are developed on either side of the Buckreef Main Zone as fault splays from the main Buckreef fault shear zone. These splays were probably developed during the reactivation of the main Buckreef northeast shear. The near surface intercepts on the Hanging wall and Footwall zones are developed in the oxide zone and within quartz-carbonate-pyrite altered zones of basaltic and dolerite rock units. These particular units offer the best opportunity to increase the size of the proposed open pit at Buckreef.

The Footwall Zone is located 50-100m in the immediate vicinity of the Buckreef Main zone while the Hanging wall Zone is located approximately 75m in the Hanging wall of the Buckreef Main zone. As part of the ongoing resource definition drilling program at Buckreef, the Company commenced a Phase 2 RC drilling program on the Buckreef Main Zone and its northern strike extension to verify previous drilling results and establish the strike and down-dip continuity of mineralization identified in previous drilling.

“The latest results would seem to confirm our initial expectations about the potential in these areas,” says Jim Sinclair, President and CEO. “However, the deep-seated higher grade potential we are also seeing has proved even more intriguing,” he notes. “This is reminiscent of my early experience when I was Chairman of the Company that owned the Bulyanhulu gold mine.”

According to Sinclair, “Gold deposits in these type greenstone belts run deep and we intend to test this hypothesis at Buckreef in the coming months.”

The Buckreef Project consists of four prospects including the dormant historic Buckreef Gold Mine at the western limit of the project area, the Tembo and Bingwa prospects, and the Buziba prospect 20km to the east. The Company has been conducting resource definition exploration drilling in the immediate vicinity of the Buckreef Main deposit where at least three additional prospective shears (Eastern Porphyry, Buckreef Footwall and Buckreef Hanging-wall) were identified based on previous historical drilling by IAMGOLD. None of these results were released into the public record.

Down-the-hole lithological sequences comprise a series of mafic basaltic rock units alternating with dolerite and a series of narrow felsic porphyry units with pronounced shearing and alterations of the mafic packages at the contacts with the felsic porphyry units. Mineralization is localized within the sheared, quartz-carbonate-pyrite altered zones, preferably associated with the dolerite/felsic porphyry units and in thin quartz veins within the sheared and altered felsic porphyry.

Analysis

Samples from RC and diamond drill-holes were submitted to SGS Lab in Mwanza for 50g fire assay (FA) with AAS finish (0.01ppm LLD). Duplicates and Standards were inserted in the sample stream approximately every 20 samples. The average percentage of recovery core is 95%. The planning, execution and monitoring of quality control programs at the Buckreef Gold project are under the supervision of Messrs. Charles Mnguto and Phillip Kaniki who are both registered Professional Geologists. Charles is the Head of Geology while Phillip is the Geology Resource Manager for the Company.

Qualified Person

The Company’s Qualified Person, Mr. Peter Zizhou, has reviewed and approved the contents of this news release. Mr. Zizhou is the General Manager (Exploration & Admin) of Tanzanian Royalty Exploration Corporation Limited. He has a Master of Science (Exploration Geology) degree from the University of Zimbabwe (2000) and is a registered scientist with SACNASP (Reg. No.400028/08).

Respectfully Submitted,

Joseph Kahama
Chairman and Chief Operating Officer (Tanzania)

For further information, please contact Investor Relations at 1-800-811-3855
Visit our website: www.TanzanianRoyalty.com

The Toronto Stock Exchange and NYSE Amex Equities have not reviewed and do not accept responsibility for the adequacy or accuracy of this release

Cautionary Note to U.S. Investors – The United States Securities and Exchange Commission limits disclosure for U.S. reporting purposes to mineral deposits that a company can economically and legally extract or produce. We use certain terms on this news release, such as “reserves”, “resources”, “geologic resources”, “proven”, “probable”, “measured”, “indicated”, or “inferred” which may not be consistent with the reserve definitions established by the SEC. U.S. Investors are urged to consider closely the disclosure in our SEC filings. You can review and obtain copies of these filings from the SEC’s website at http://www.sec.gov/edgar.shtml

This news release contains certain forward-looking statements and forward-looking information. All statements, other than statements of historical fact, included herein are forward-looking statements and forward-looking information that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time-to-time with the British Columbia, Alberta and Ontario provincial securities regulatory authorities.

Certain information presented in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on numerous assumptions, and involve known and unknown risks, uncertainties and other factors, including risks inherent in mineral exploration and development, which may cause the actual results, performance, or achievements of the Company to be materially different from any projected future results, performance, or achievements expressed or implied by such forward-looking statements. Investors are referred to our description of the risk factors affecting the Company, as contained in our SEC filings, including our annual report on Form 20-F and Registration Statement on Form F-10, as amended, for more information concerning these risks, uncertainties, and other factors.

To view this release as a web page, please click on the following link:
http://www.usetdas.com/pr/tanzanian01232012.htm

Connecticut Office:
93 Benton Hill Road
Sharon, CT 06069
Tel: (860) 364-1830
Fax: (860) 364-0673

South Surrey Office:
Suite 404 – 1688 152nd Street
South Surrey, BC V4A 4N2
Email: investors@TanzanianRoyalty.com
Website: www.TanzanianRoyaltyExploration.com

Toll Free: 1-800-811-3855
Tel: (604) 536-7873
Fax: (604) 536-2529

Biostar Pharmaceuticals (BSPM) Selected by the FMMU to Cooperate in the Fields of Research and Product Development

XIANYANG, China, Jan. 23, 2012 /PRNewswire-Asia-FirstCall/ — Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) (“Biostar” or “the Company”), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that on January 8th it was one of nine PRC pharmaceutical companies selected to cooperate with The Fourth Military Medical University (“FMMU”) (website: http://en.fmmu.edu.cn) in the fields of research and product development.

Established in 1954 and based in Xi’an, FMMU is one of China’s most prestigious military medical universities and research centers. FMMU consists of several colleges specializing in: basic medicine, aerospace medicine, stomatology (the study of oral diseases), biomedical engineering, military services and statistics, pharmacology, nursing, and operates three modern hospitals: the First Affiliated General Hospital, the Second Affiliated General Hospital and the Stomatological Hospital.

FMMU’s primary purpose is to advance China’s military medicine. Before selecting Biostar, to the best of the Company’s understanding, FMMU screened various pharmaceutical companies, rating their achievements in several fields, including research and product development, their completion of clinical trials, and their products’ significance in fighting widespread diseases.

During his speech at the January 8th ceremony, which was attended by more than 3,000 doctors, university professors, leaders in the medical field, and executives from more than 500 pharmaceutical companies, Biostar’s Chairman and Chief Executive Officer, Mr. Ronghua Wang, noted that Biostar will work with FMMU’s staff to share resources and ideas and to carry out phases I to IV of clinical trials for products covered under the cooperation agreement. Additionally, based on and in accordance with prescribed military guidelines, Biostar’s researchers will develop products which, when approved, will be sold directly to the PRC military and to the three hospitals managed by FMMU. The Company anticipates that its Zushima spray, a pain suppressant, which Biostar developed for China’s military and has cleared clinical trials, will receive a military license shortly.

Mr. Ronghua Wang noted, “We are proud to be one of only nine pharmaceutical companies in China selected to cooperate with FMMU. When compared to the other eight pharmaceutical companies in this group, Biostar is smaller, but our vertically integrated business model, our strong R&D, and our manufacturing and marketing capabilities were several of the reasons why Biostar was included in this group. For several years, we have been cooperating with many prestigious universities, such as Shaanxi College of Traditional Chinese Medicine, Shaanxi University of Science and Technology and the Northwest University – College of Life Science. We believe that through our cooperation with FMMU, we have positioned the Company to take advantage of the growth forecasted for the pharmaceutical industry. We remain committed to enhancing shareholder value by expanding our product range, increasing sales, and profitably growing our Company.”

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company’s most popular product is its Xin AoXing Oleanolic Acid Capsule, an over-the-counter (“OTC”) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com

Safe Harbor relating to the Forward-Looking Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company uses words and phrases such as “guidance,” “forecasted,” “projects,” “is expected,” “remain confident,” “will” and similar expressions to identify forward-looking statements in this press release, including forward-looking statements. Undue reliance should not be placed on forward-looking information. Forward-looking information is based on current expectations, estimates and projections that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Biostar and described in the forward-looking information contained in this news release. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the Company’s ability to achieve its growth strategy, its ability to licensing and commercializing approval of the Zushima spray and other Company products, to incorporate and successfully develop additional drugs into the Company’s existing product portfolio, its ability to capitalize on the market opportunities presented by such acquisition, regulatory and other related approvals relating to the acquisition, the Company’s ability to integrate this acquisition into its current operations, its ability to complete the audit and other closing conditions relating to the acquisition, success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, our ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our most recent Annual Report on Form 10-K for the year ended December 31, 2010, and other subsequent filings. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

Ur-Energy (URG) Enters Into New Uranium Sales Agreement

LITTLETON, Colo., Jan. 23, 2012 /PRNewswire/ — Ur-Energy Inc. (TSX:URE, NYSE Amex:URG) (“Ur-Energy” or the “Company”) is pleased to announce that it has entered into a new uranium supply agreement with a North American based utility company. The contract calls for total deliveries of 200,000 pounds of uranium concentrate per year in a multi-year schedule commencing in 2013. The average delivery price under the agreement is consistent with the current Long-Term U3O8 Price Indicator published by Trade Tech.

The successful completion of this supply agreement moves Ur-Energy closer to fulfilling the marketing strategy that the Company developed under an arrangement entered into with Mr. Jim Cornell of NuCore Energy, in October of last year. The strategy calls for Ur-Energy to sell a pre-determined portion of the expected uranium production capacity from its Lost Creek Project in term agreements with North American nuclear utilities at prices that will ensure the project’s financial viability. The contract, together with others that Ur-Energy expects to complete in the near future, constitutes a very important aspect of the Company’s growth strategy. Ur-Energy expects to begin production from Lost Creek in the second quarter of 2013 and ramp up production to near one million pounds per year in 2014.

Ur-Energy CEO Wayne Heili said, “We are very pleased that our newest utility customer expressed its confidence in our team and the Lost Creek Project by agreeing to establish a supply relationship with us. This supply arrangement is a critical component of our overall growth strategy as it contributes to the future financial viability of our U.S. based uranium mining operations.”

About Ur-Energy

Ur-Energy is a junior uranium company currently completing mine planning and permitting activities to bring its Lost Creek Wyoming uranium deposit into production. Permitting also will allow the construction of a two-million-pounds-per-year in situ uranium processing facility. Engineering for the process facility is complete and mine planning is at an advanced stage for the first two mine units. Ur-Energy engages in the identification, acquisition and exploration of uranium properties in both Canada and the United States. Shares of Ur-Energy trade on the Toronto Stock Exchange under the symbol “URE” and on the NYSE Amex under the symbol “URG”. Ur-Energy’s corporate office is located in Littleton, Colorado; its registered office is in Ottawa, Ontario. Ur-Energy’s website is www.ur-energy.com.

This release may contain “forward-looking statements” within the meaning of applicable securities laws regarding events or conditions that may occur in the future (e.g., timetables at Lost Creek; the ability to complete additional uranium sales agreements and on what terms; successful implementation of the growth strategy of the Company; receipt of (and related timing of) the Record of Decision of the BLM related to the Lost Creek Plan of Operations; and the sustainability, timeline and future profitability of Lost Creek production) and are based on current expectations that, while considered reasonable by management at this time, inherently involve a number of significant business, economic and competitive risks, uncertainties and contingencies. Factors that could cause actual results to differ materially from any forward-looking statements include, but are not limited to, capital and other costs varying significantly from estimates; failure to establish estimated resources and reserves; the grade and recovery of ore which is mined varying from estimates; production rates, methods and amounts varying from estimates; delays in obtaining or failures to obtain required governmental, environmental or other project approvals; inflation; changes in exchange rates; fluctuations in commodity prices; delays in development and other factors. Readers should not place undue reliance on forward-looking statements. The forward-looking statements contained herein are based on the beliefs, expectations and opinions of management as of the date hereof and Ur-Energy disclaims any intent or obligation to update them or revise them to reflect any change in circumstances or in management’s beliefs, expectations or opinions that occur in the future. Additional risks relating to Ur-Energy may be found in current and periodic reports filed by Ur-Energy with Canadian securities regulatory authorities on www.sedar.com and the US SEC at http://www.sec.gov/edgar.shtml.

EntreMed (ENMD) Secures $10 Million Strategic Financing

ROCKVILLE, Md., Jan. 23, 2012 /PRNewswire/ — EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P. (“IDG”), Emerging Technology Partners, LLC (“ETP”), and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.

The Company entered into purchase agreements with the investors, pursuant to which the Company has agreed to issue and sell to the investors convertible notes in the aggregate principal amount of $10 million. The investors also will be issued warrants covering a number of shares of common stock equal to 20% of the principal amount of the notes, divided by $1.15. The warrants are exercisable at $1.40 per share. The closing of the transaction is anticipated to occur on or about January 27, 2012 upon the satisfaction of certain conditions.

At the closing, IDG and ETP have the right to designate in the aggregate two members of the Company’s Board of Directors. In addition, it is expected that the Company will select an interim Chief Executive Officer.

Subject to the approval of the Company’s stockholders at the 2012 stockholder meeting, the notes will automatically and immediately convert into shares of common stock and the warrants will become exercisable. The notes have a maturity date of August 31, 2012, bear an interest rate of 6% and will convert at a conversion price of $1.15 per share. The conversion price reflects the 10-day average closing sale price ending on January 20, 2012. The notes are not convertible, and the warrants are not exercisable, prior to receiving stockholder approval. If stockholder approval is not obtained, the Company will be required to pay liquidated damages to the note purchasers equal to an aggregate of $1.2 million.

“We are very pleased to have the support from a group of knowledgeable investors and the validation of the potential of ENMD-2076. The proceeds from the notes will allow the Company to accelerate and expand its research and development activities, fund additional trials, initiatives and long term strategic plans,” said Michael M. Tarnow, the Company’s Executive Chairman.

After deducting transaction fees and expenses, the net proceeds to the Company will be approximately $9.3 million. The convertible notes, the warrants and the common stock into which the notes and warrants are convertible have not been registered under the Securities Act of 1933, as amended (the “Act”) and applicable state securities laws, but have been offered and sold in the United States pursuant to applicable exemptions from registration requirements under the Act and applicable state securities laws. This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

About ENMD-2076
ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma. ENMD-2076 is currently in a Phase 2 trial for ovarian cancer, and preclinical and clinical activities are ongoing in assessing the compound’s applicability for other forms of cancer.

About EntreMed
EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer. ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia. Additional information about EntreMed is available on the Company’s web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About IDG-Accel Fund
IDG-Accel Fund is a private equity investment fund focused on investment in various sectors and is managed by IDG Capital Partners, a leading investment management team in China with over 18-years of investment experience and industry knowledge.

Forward Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; our reliance on a single product candidate, ENMD-2076 and the risk that we may not be able to license it to a third party; the volatility of our common stock; our history of losses and expectation of incurring continued losses; risks relating to the need for additional capital, including the uncertainty of securing additional funding on favorable terms and the risk that we will not be able to drawdown the full amount of funding available under our standby equity distribution agreement; the need for additional funds to conduct any additional clinical trials, our dependence on royalty sharing agreement based on sales of a product, Thalomid^®, that we do not control; declines in actual sales of Thalomid^® resulting in materially reduced royalty payments; risks associated with our product candidates; results in preclinical models that are not necessarily indicative of clinical results; risks relating to the commercialization, if any, of our proposed products (such as marketing, safety, regulatory, patent, product liability, supply and other risks); and our ability to compete with larger, better financed biotechnology companies that may develop new approaches to the treatment of our targeted diseases or develop product candidates more advanced than ENMD-2076. Such factors, among others, could have a material adverse effect upon our business, results of operations and financial condition. We caution readers not to place undue reliance on any forward-looking statements, which only speak as of the date made. Additional information about the factors and risks that could affect our business, financial condition and results of operations, are contained in our filings with the SEC, which are available at www.sec.gov.

COMPANY CONTACT:
Investor Relations
EntreMed, Inc.
240.864.2643
investorrelations@entremed.com

Net 1 UEPS Technologies, Inc. (UEPS)

Net 1 UEPS Technologies Inc. is focused on providing its Universal Electronic Payment System (“UEPS”) as an alternative payment system for the unbanked and under-banked populations of developing economies. The company’s system enables the estimated four billion people who generally have limited or no access to a bank account, to enter into electronic transactions with each other, government agencies, employers, merchants and other financial service providers.

UEPS works by using real-time smart cards that have offline functionality, unlike traditional payment systems offered by major banking institutions that require immediate connectivity to a network. This offline capability allows users of the Net 1 system to enter into transactions at any time with other card holders, even in the most remote areas, as long as a portable offline smart card reader is available. In addition to payments and purchases, UEPS can be used for banking, healthcare management, international money transfers, voting and identification.

Net 1 also focuses on the development and provision of secure transaction technology, solutions and services and offers transaction processing, financial and clinical risk management solutions to both funders and providers of healthcare. The company’s core competencies around secure online transaction processing, cryptography and integrated circuit card technologies are mainly applied to electronic commerce transactions in the telecommunications, banking, retail, petroleum and utilities market sectors.

Key Investment Highlights:

• Addressing Unmet Financial Needs in Developing Economies
• Ever Growing Product Offering and Distribution Channels
• Proprietary Payment System Boasts Proven Track Record
• Target Market Encompasses 50% of the World’s Population

Longhai Steel, Inc. (LGHS)

Longhai Steel, Inc. is a leading producer of high-quality steel wire in eastern China, with annual capacity of 1.5 million metric tons. Longhai’s wire is manufactured into screws, nails, and wire mesh used for fencing and to reinforce concrete. Longhai recently expanded its production facility to include specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod. Longhai Steel is headquartered in Xingtai, Hebei province, the People’s Republic of China.

The company’s competitive advantages are its advanced production equipment and process technology, high product quality, expedited production, and close proximity to distributors and end users. Longhai Steel recently opened a second production line, which increases its overall capacity by 67% and expands its product portfolio into higher quality steel wire for specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod.

Longhai Steel’s growth strategy includes capitalizing on government actions aimed at encouraging industry consolidation via the acquisition of neighboring producers at attractive valuations. The company also plans to grow organically through capacity expansion, broadening its product portfolio, improving operating efficiencies, and continued expansion of technical expertise.

China is the world’s largest producer and consumer of steel and steel wires. Demand for steel products is primarily driven by spending in the construction, automotive, and infrastructure industries in China. Continued economic development in Hebei, one of the largest steel manufacturing regions in China, and neighboring provinces, and further buildout of tier 3-6 cities in China, provide tremendous medium and long term opportunities for Longhai Steel.

Key Investment Highlights:

• Positioned to Achieve Meaningful, Near-term Growth
• Reputation and Experience as a Leading Wire Provider in Hebei Province
• Strong Track Record of Industry-leading Efficiencies
• Best Practices in Corporate Governance and Transparency

Mercury Computer Systems, Inc. (MRCY)

Mercury Computer Systems provides superior open, commercially developed, application-ready, multi-INT subsystems for the Intelligence, Surveillance and Reconnaissance (ISR) market. With more than 30 years of experience solving highly challenging computing problems in the defense industry, the company also provides unparalleled domain expertise in radar, EW/SIGINT, EO/IR, C4I and sonar applications.

Embedded computing subsystems have become the lifeblood of innovation. They essentially empower the systems at the root of some of the world’s most important industrial devices. Mercury Computer Systems delivers these high-performing communications subsystems based on a steadfast commitment to open-standard technology.

The company’s Services and Systems Integration team (SSI) partners with its customers to design and integrate signal and image processing subsystems that minimize program risk, maximize application portability and accelerate time to deployment. Throughout its history, Mercury has worked in concert with 26 prime contractors to successfully execute more than 300 deployments on programs such as Aegis, Global Hawk, JCREW, Patriot, Predator and SEWIP.

With $355.6 million in total assets, $162.8 million of which consists of cash and cash equivalents, Mercury Computer Systems has approximately $54.1 million in total liabilities. Currently four analysts recommend the stock as a “Strong Buy”, three call it a “Buy”, and three have issued a “Hold” recommendation. The average price target is currently $24.50, significantly higher than the current market price.

Key statistics (9/6/11):

Market cap: $386.39 Million
P/E Ratio: 18.3 versus industry average of 9.7
P/S Ratio: 1.73 versus industry average of 11.63
Price/Book Ratio: 1.26 versus industry average of 2.61

Gross Profit Margin: 56.8% versus industry average of 45.1%
Pre-Tax Margin: 11.6% versus industry average of -6.4%
Net Profit Margin: 8.1% versus industry average of -8.0%
Asset Turnover (Management Efficiency): 0.8 vs 0.7

Debt/Equity Ratio: 0.00 versus industry average of 0.26
Current Ratio: 6.6 versus industry average of 5.5
Return on Equity: 7.7% versus industry average of -1.6%
5-Year average ROE: 2.4% versus industry average of -2.2%

GlobalWise Investments, Inc. (GWIV)

GlobalWise Investments, Inc., via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today’s business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise’s ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise’s management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry.

Key Investment Highlights:

• Cutting-Edge Solutions that Increase Productivity and Cut Costs
• ECM Industry Expected to Exceed $5.7 Billion by 2014 with 10.1% CAGR
• Industry’s First ECM App Store to Drive Mobility Usage and Capability
• Market Leader with Proprietary Software and Experienced Management

FluoroPharma Medical, Inc. (FPMI)

FluoroPharma Medical, Inc. is a biopharmaceutical company focused on discovering and developing patented Positron Emission Tomography (PET) imaging products to improve patient management by evaluating cardiac disease at the cellular and molecular levels. The company is currently advancing two products in clinical trials to fulfill critical unmet medical needs. The agents will provide clinicians important tools for detecting and assessing pathology before critical manifestations of disease.

The company’s proprietary molecules labeled with the radioactive isotope of fluorine combined with PET scanning provide non-invasive, highly specific and efficient assessment of heart metabolism and physiology. FluoroPharma’s cardiovascular program addresses the largest segment of the nuclear medicine market.

Molecular imaging fulfills numerous unmet needs in diagnosis by enabling visualization, characterization and measurement of biological processes at the molecular and cellular level. Unlike traditional imaging modalities – MRI, CT, and Ultrasound – that reveal the anatomical abnormalities and cause for disease, PET provides insight into physiology and can detect disease before anatomical manifestation is identified. According to GAI, the market for molecular imaging agents currently exceeds $1.7 billion annually and promises rapid growth for the foreseeable future.

FluoroPharma’s comprehensive technology platform was developed by scientists at the Massachusetts General Hospital. To date, the company has been issued four US patents and has seven applications pending in addition to strong international protection. With a solid and experienced management team in place and the necessary resources to advance clinical development, FluoroPharma is well positioned to capitalize on its superior imaging technology.

Key Investment Highlights:

• Clinical Trials Confirmed Technologies are Safe and are Now Establishing their Efficacy
• Intellectual Property in Place to Protect Proprietary Innovations Around the World
• Cash On Hand to Accelerate Business Strategy
• Technology Targets Multiple, Multimillion Dollar Healthcare Markets with Strong / Unmet Medical Needs

AdCare Health Systems, Inc. (ADK)

AdCare Health Systems, Inc. is an expanding national leader in the development, ownership, and management of assisted living facilities, skilled nursing and retirement communities. The company’s 3,600 employees provide high-quality care for patients and residents residing in the 44 facilities that it operates with a total of approximately 3,900 beds/units in service.

As a result of better health management and treatments allowing people to live longer, the Census Bureau projects that the population aged 85 and over could grow from 5.7 million in 2008 to 19 million by 2050. AdCare has been successfully pursuing an aggressive M&A growth strategy to bolster its portfolio during a depressed economic climate to capitalize on the imminent demand for senior care over the coming decades.

The fragmented skilled nursing market presents significant consolidation and acquisition opportunities to well-established providers like AdCare. With approximately 16,000 facilities currently in operation, no single provider has a market share of more than a few percent. Leveraging its seasoned senior management team’s substantial senior living, healthcare, and real estate industry experience, the company is focused on advancing its strategic business plan to operate a much larger enterprise.

Since inception, AdCare’s mission has been to provide the highest quality healthcare services to the elderly. With nine straight years of record revenue growth, the company has proven its ability to deliver high-quality care and strong operational efficiency. AdCare is well positioned to continue growing rapidly, both organically and via acquisitions, as industry trends and burgeoning opportunities across the U.S. increase the demand for long-term care.

Key Investment Highlights:

• Aggressive M&A Growth Strategy to Capitalize on Expanding $226 Billion Market
• Long-term Care Market Poised for Steady Expansion through 2050
• More than 25% of Outstanding Shares Owned by Management Team
• Well Established with Nine Straight Years of Record Revenue Growth

Cardium Therapeutics, Inc. (CXM)

GlobalWise Investments, Inc., via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today’s business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise’s ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise’s management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry.

Key Investment Highlights:

• Cutting-Edge Solutions that Increase Productivity and Cut Costs
• ECM Industry Expected to Exceed $5.7 Billion by 2014 with 10.1% CAGR
• Industry’s First ECM App Store to Drive Mobility Usage and Capability
• Market Leader with Proprietary Software and Experienced Management

ECOtality (ECTY) Appoints Kevin Cameron to Board of Directors

ECOtality, Inc. (NASDAQ:ECTY), a leader in clean electric transportation and storage technologies, announced today Kevin Cameron has been appointed to the Company’s Board of Directors, effective January 17, 2012. Mr. Cameron will assume the position on the board previously held by Colonel Barry S. Baer. Colonel Baer will continue with his position as Secretary/Assistant Treasurer of the Company.

“We are pleased to have Mr. Cameron joining our Board of Directors, with Colonel Baer continuing on his role as Treasurer of ECOtality,” stated Jonathan Read, CEO of ECOtality, Inc. “Mr. Cameron brings many years of experience in executive management and we believe that, given his background in technology, governance, and communication, he will be a valuable asset to our team in guiding the mass adoption of electric vehicles and infrastructure necessary for success.”

Mr. Cameron is currently Chief Executive Officer of Ionetix Corporation, a privately held medical device company. Prior to joining Ionetix Corporation in March 2011, Mr. Cameron was a co-founder and president of Glass Lewis & Co. LLC, a leading provider of corporate governance services to institutional investors. Previously, Mr. Cameron was employed in various capacities by Moxi Digital and NorthPoint Communications. Mr. Cameron started his career as an attorney with the law firm of Kellogg, Huber, Hansen, Todd & Evans in Washington D.C., before which he was a law clerk for the United States Court of Appeals for the District of Columbia Circuit. Mr. Cameron holds a law degree from the University of Chicago and an undergraduate degree from McGill University in Canada. Mr. Cameron is currently a board member of Keryx Biopharmaceuticals, Inc. (NASD: KERX) and Reddy Ice Holdings, Inc. (NYSE: FRZ).

About ECOtality, Inc.

ECOtality, Inc. (NASDAQ:ECTY), headquartered in San Francisco, California, is a leader in clean electric transportation and storage technologies. Through innovation, acquisitions, and strategic partnerships, ECOtality accelerates the market applicability of advanced electric technologies to replace carbon-based fuels. For more information about ECOtality, Inc., please visit www.ecotality.com.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements.

Colony Bankcorp, Inc. (CBAN) Announces Fourth Quarter Results and Board Chairman Retirement

FITZGERALD, Ga., Jan. 20, 2012 (GLOBE NEWSWIRE) — Colony Bankcorp, Inc. (Nasdaq:CBAN), today reported net income available to shareholders of $31,000, or $0.00 per diluted share for the fourth quarter of 2011 compared to fourth quarter 2010 net loss available to shareholders of $47,000, or $(0.01) per diluted share, while net income available to shareholders for twelve months ended December 31, 2011 was $1,134,000, or $0.13 per diluted share compared to net loss available to shareholders for the comparable period in 2010 of $926,000, or $(0.11) per diluted share. This increase of 222.46 percent in net income for the comparable twelve month periods was primarily driven by the reduction in loan loss provision to $8.25 million for the twelve months ended December 31, 2011 from $13.35 million for the comparable period in 2010. “Our pre-tax, pre-provision core earnings continue to provide solid support for the credit-related expenses needed to address our problem assets. We are cautiously optimistic that our nonperforming assets have peaked as the past two quarters we have seen our nonperforming assets reduce from $65.81 million at June 30, 2011 to $59.71 million at December 31, 2011, or a decrease of 10.22 percent. We still have much work ahead in reducing our problem assets to an acceptable level and returning to our accustomed earnings standards, but we feel that much has been accomplished toward our goal of making incremental progress in 2011,” said Terry L. Hester, Executive Vice President and Chief Financial Officer.

Capital

Colony continues to maintain a favorable capital position to be categorized as “well-capitalized” by regulatory benchmarks. At December 31, 2011, the Company’s tier one leverage ratio, tier one and total risk-based capital ratios were 9.42 percent, 15.07 percent and 16.33 percent, respectively, compared to the previous quarter end of 9.33 percent, 15.38 percent and 16.64 percent, respectively, at September 30, 2011 and to 8.59 percent, 13.55 percent and 14.83 percent, respectively, at December 31, 2010. Regulatory benchmarks to be categorized as “well-capitalized” for tier one leverage ratio, tier one and total risk-based capital ratios are 5.00 percent, 6.00 percent and 10.00 percent, respectively.

Net Interest Margin

During the fourth quarter of 2011, the Company reported net interest income of $8.84 million and a net interest margin of 3.28 percent, compared to $8.88 million and 3.02 percent, respectively, for fourth quarter 2010. While anemic loan demand continues to hamper net interest margin, the Company continues to focus on maximizing its net interest margin through deposit and loan pricing guidance. Those efforts reflected significant improvement during the year as net interest margin increased to 3.28 percent for fourth quarter 2011 compared to 3.21 percent for third quarter 2011 and compared to 2.98% for the first half of 2011.

Asset Quality

The Company continues to closely monitor our non-performing assets and focus on problem asset resolution. Non-performing assets decreased from the previous quarter end to $59.71 million or 8.10 percent of total loans and other real estate owned as of December 31, 2011. This compares to $63.29 million or 8.31 percent and $49.26 million or 5.91 percent, respectively, as of September 30, 2011 and December 31, 2010. The level of non-performing assets ties directly to the elevated risk in our residential, land development and commercial real estate loan portfolio and has resulted in higher than normal loan loss provisions the past several years. Unusually high levels of loan loss provisions have been required the past several years as company management addresses asset quality deterioration associated with the housing and real estate downturn and the economy in general. Loan loss reserve methodology resulted in provision for loan losses of $8.25 million in twelve months ended December 31, 2011 compared to $13.35 million for the comparable 2010 period. Until we see stabilization in the economy and the housing and real estate market, we expect problem assets and charge-offs to be elevated above historical levels as we work through our problem assets.

In the fourth quarter of 2011 net charge-offs were $3.51 million, or 0.48 percent of average loans as compared to net charge-offs of $1.97 million, or 0.24 percent of average loans in fourth quarter 2010, while net charge-offs in twelve months ended December 31, 2011 were $20.88 million, or 2.74 percent of average loans as compared to net-charge-offs of $16.47 million, or 1.90 percent of average loans in the comparable 2010 period. Restructuring of some substandard and non-performing loans during 2011 has resulted in significant charge-offs, but a strategy deemed prudent in bringing resolution with these credits and a return to performing status in the future. The loan loss reserve was $15.65 million on December 31, 2011, or 2.18 percent of total loans compared to $16.91 million on September 30, 2011, or 2.28 percent of total loans. Management believes that the 2011 contributions to Allowance for Loan Losses address the level of non-performing assets and the related level of classified assets to be adequately reserved at December 31, 2011.

Noninterest Income

Total noninterest income decreased slightly in the comparable periods as twelve months ended December 31, 2011 noninterest income was $9.95 million compared to $10.01 million in the comparable 2010 period. Gains realized from the sale of securities totaled $2.92 million in twelve months ended December 31, 2011 compared to a gain recorded on security transactions during the comparable period in 2010 of $2.62 million. The Company has been successful in generating SBA loans during the year and has realized $947 thousand from the sale of SBA loans in twelve months ended December 31, 2011 compared to $1.04 million SBA fee income for the comparable 2010 period. The SBA lending program has offset the decline in service charge on deposit fee income which has been impacted by recent regulatory changes with Regulation E.

Noninterest Expense

Total noninterest expense decreased to $33.05 million in twelve months ended December 31, 2011 compared to $33.86 million in the comparable 2010 period, or a decrease of 2.39 percent. Credit-related expenses including write down and losses on OREO property and repossession and foreclosure expenses decreased to $4.05 million in twelve months ended December 31, 2011 compared to $4.94 million in the comparable 2010 period. Salaries and employee benefits expenses increased to $14.63 million in twelve months ended December 31, 2011compared to $14.10 million in the comparable 2010 period, or an increase of 3.80 percent. This increase is primarily attributable to an increase in headcount related to increased regulatory compliance demands. Occupancy expenses decreased to $4.00 million in twelve months ended December 31, 2011 compared to $4.42 million in the same comparable 2010 period, or a decrease of 9.60 percent. The decrease was primarily attributable to less depreciation expense for the comparable periods.

Recent Development

Chairman Morris Downing tendered his resignation as Director and Chairman of the Board of Colony Bankcorp, Inc. and Colony Bank effective January 17, 2012 for personal health reasons. Mr. Downing has served as a Director of Colony Bankcorp, Inc. since July 1994 and Chairman of the Board since May 2002 and as Chairman and Director of Colony Bank since the Company merged its seven banking charters into the lead bank in 2008. Also, Mr. Downing served as President for 35 years of Lowell Packing Company in Fitzgerald, Georgia. He also served as a member of the Board of Trustees for AgriTrust of Georgia, a self-insured workers’ compensations insurance program designed by the Georgia Agribusiness Council, Inc. and past President of Southeastern Meat Association and was active in Forward Fitzgerald. The Board of Directors expresses its sincere gratitude to Mr. Downing for his commitment to the company for the past seventeen years. His experience in business, management and valuable leadership has made great contributions to the company’s success.

The Board of Directors announced that B. Gene Waldron has been elected the new Chairman of Colony Bankcorp, Inc. and Colony Bank effective immediately, upon Mr. Downing’s resignation. Mr. Waldron has been a Director of Colony Bankcorp, Inc. since 2002 and served as a Director of Colony Bank since August 2008, where he previously served as a Director and Chairman of the Board of the Colony Bank Southeast charter. Mr. Waldron is the President/Owner of Waldron Enterprises, Inc. in Douglas, Georgia, whose entities are involved in peanut buying, cotton ginning, fertilizer and chemical sales, farming, radio broadcasting and fuel distribution. The Board of Directors feel that Mr. Waldron’s business experience makes him an excellent choice for the position as Chairman of the Board.

Colony Bankcorp, Inc. is a bank holding company headquartered in Fitzgerald, Georgia that consists of one operating subsidiary, Colony Bank. The Company conducts a general full service commercial, consumer and mortgage banking business through thirty offices located in the middle and south Georgia cities of Fitzgerald, Warner Robins, Centerville, Ashburn, Leesburg, Cordele, Albany, Thomaston, Columbus, Sylvester, Tifton, Moultrie, Douglas, Broxton, Savannah, Eastman, Chester, Soperton, Rochelle, Pitts, Quitman and Valdosta, Georgia.

Colony Bankcorp, Inc. Common Stock is quoted on the Nasdaq Global Market under the symbol “CBAN”.

Certain statements contained in the preceding release that are not statements of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”), notwithstanding that such statements are not specifically identified. In addition, certain statements may be contained in the Company’s future filings with the SEC, in press releases, and in oral and written statements made by or with the approval of the Company that are not statements of historical fact and constitute forward-looking statements within the meaning of the Act. Examples of forward-looking statements include, but are not limited to: (i) projections of revenues, income or loss, earnings or loss per share, the payment or nonpayment of dividends, capital structure and other financial items; (ii) statement of plans and objectives of Colony Bankcorp, Inc. or its management or Board of Directors, including those relating to products or services; (iii) statements of future economic performance; and (iv) statements of assumptions underlying such statements. Words such as “believes,” “anticipates,” “expects,” “intends,” “targeted” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements.

Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those in such statements. Forward-looking statements speak only as of the date on which such statements are made. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events. Readers are cautioned not to place undue reliance on these forward-looking statements.

CONTACT: Terry L. Hester
         Chief Financial Officer
         (229) 426-6002

CEL-SCI Corporation (CVM) Releases Letter to Shareholders

Insmed Inc. (INSM) Provides Corporate Update

Picochip (SNPS) Achieves First Silicon Success for 40-nm picoXcel Femtocell Chip Using Synopsys’ Lynx Design System

MOUNTAIN VIEW, Calif., Jan. 18, 2012 /PRNewswire/ — Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design, verification and manufacturing, today announced that Picochip Ltd., who recently signed a definitive agreement to be acquired by Mindspeed Technologies Inc. (NASDAQ: MSPD), has successfully achieved first silicon success using Synopsys’ Lynx Design System and Galaxy™ Implementation Platform in the design of its next-generation 40-nanometer (nm) PC3008 picoXcell femtocell chip optimized for high-volume, cost-sensitive consumer applications. The Lynx Design System enabled Picochip’s engineering team to quickly and efficiently upgrade to a pre-tested 40-nm Galaxy-based production design flow, saving significant time and effort compared to developing their own flow. In addition, Lynx’s Foundry-Ready System enabled Picochip’s engineers to begin design work within two weeks of initial deployment, accelerating their project start date by an estimated eight weeks.

“In the mobile communications market, each product generation requires higher performance and functionality at a lower cost. For Picochip to deliver this, it is essential that we are able to migrate process technololgies quickly and easily,” said Will Robbins, vice president of silicon at Picochip. “Synopsys’ Lynx gave us a robust Galaxy-based RTL-to-GDSII design flow, which we could configure to our specific technology needs. This gave us a head start over simply having a set of tools with which to build a design flow. It allowed us to tape out our first 40-nanometer chip, whilst saving us months of R&D effort.”

Picochip is a leader in developing system-on-chip (SoC) solutions for the mobile communications infrastructure market, with an award-winning portfolio of cost- and performance-optimized silicon devices that change the way mobile networks are architectured. The PC3008 is the first in a family of devices that support the HSPA+ wireless broadband standard, delivering a low bill of material cost silicon device. It supports eight users with Release 9 HSPA+ (21Mbps downlink, 5Mbps uplink), incorporating Picochip’s field-proven robust PHY and a 1GHz ARM11™ processor with TrustZone®.

The Lynx Design System is a complete chip design environment that includes a production-proven design flow enabled by Galaxy tools with innovative visualization capabilities to help create and track designs throughout the implementation cycle. Picochip adopted Lynx to mitigate the cost and risk of creating and maintaining a new production flow for its first 40-nm design and to meet an aggressive project schedule. Using Lynx, Picochip’s engineers were able to immediately focus on optimizing the new design to meet both their 1GHz performance target and aggressive development cycle.

“The Lynx Design System offers tangible benefits for design teams looking to reduce the cost and risk of migrating to new technology processes,” said John Koeter, vice president of marketing for IP and systems at Synopsys. “By enabling designers to implement chips more efficiently without sacrificing quality of results, and attacking total cost of design through systematic design flow management, leading design companies like Picochip are able to focus on what they do best – delivering differentiated design solutions in a competitive marketplace.”

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is a world leader in electronic design automation (EDA), supplying the global electronics market with the software, intellectual property (IP) and services used in semiconductor design, verification and manufacturing. Synopsys’ comprehensive, integrated portfolio of implementation, verification, IP, manufacturing and field-programmable gate array (FPGA) solutions helps address the key challenges designers and manufacturers face today, such as power and yield management, system-to-silicon verification and time-to-results. These technology-leading solutions help give Synopsys customers a competitive edge in bringing the best products to market quickly while reducing costs and schedule risk. Synopsys is headquartered in Mountain View, California, and has approximately 70 offices located throughout North America, Europe, Japan, Asia and India. Visit Synopsys online at http://www.synopsys.com/.

Synopsys and Galaxy are registered trademarks or trademarks of Synopsys, Inc. Any other trademarks or registered trademarks mentioned in this release are the intellectual property of their respective owners.

Active Power (ACPW) Renews Global OEM Agreement with Caterpillar

Active Power (NASDAQ: ACPW), manufacturer of continuous power and infrastructure solutions, announced today it has renewed its global distribution agreement with its OEM partner and customer Caterpillar, Inc. (NYSE: CAT).

The new five-year contract contains substantially similar terms and conditions to the previous agreement signed in April 2008 with enhancements to reflect new products, operational processes, and pricing. As part of the distribution agreement, Caterpillar will continue to market Active Power products under the Caterpillar brand and as a complement to its own product line.

“The renewal of our global agreement with Caterpillar reflects the importance of this channel to our overall business strategy particularly as we focus now on growing and expanding our core UPS (uninterruptible power supply) business,” said Jan Lindelow, interim president and CEO, for Active Power. “This relationship broadens our sales reach as we continue to engage Caterpillar’s global dealer network which in turn creates opportunities that we would have otherwise not been exposed to.”

About Active Power

Founded in 1992, Active Power (NASDAQ: ACPW) designs and manufactures continuous power solutions and critical backup power systems that enable datacenters and other mission critical operations to remain ‘on’ 24 hours a day, seven days a week. Active Power solutions are intelligently efficient, inherently reliable and economically green, providing environmental benefits and energy and space efficiencies to customers’ financial benefit. The company’s products and solutions are built with pride in Austin, Texas, at a state-of-the-art, ISO 9001:2008 registered manufacturing and test facility. Global customers are served via Austin and three regional operations centers located in the United Kingdom, Germany, and China, supporting the deployment of systems in more than 40 countries. For more information, visit www.activepower.com.

Cautionary Note Regarding Forward-Looking Statements

This release may contain forward-looking statements that involve risks and uncertainties. Any forward-looking statements and all other statements that may be made in this news release that are not historical facts are subject to a number of risks and uncertainties, and actual results may differ materially. Specific risks include delays in new product development, product performance and quality issues and the acceptance of our current and new products by the power quality market. Please refer to Active Power filings with the Securities and Exchange Commission for more information on the risk factors that could cause actual results to differ.

Active Power and CleanSource are registered trademarks of Active Power, Inc. The Active Power logo and PowerHouse are trademarks of Active Power, Inc. All other trademarks are the properties of their respective companies.

Rainmaker (RMKR) Awarded Contract Extensions by Two Existing Software Clients for Global B2B e-Commerce Sales

Rexahn Pharmaceuticals (RNN) Secures Approval in Europe to Conduct a First-in-Human Trial of RX-3117 in Solid Tumors

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee approval for Rexahn’s initial Clinical Trial Application (CTA). This allows Rexahn to initiate an exploratory first-in-human Phase I clinical trial of RX-3117.

RX-3117 is a small molecule antimetabolite for the treatment of solid tumors.

“Preclinical studies demonstrate RX-3117 to have exciting anti-cancer properties, and we look forward to moving this compound into clinical development,” said Rick Soni, President and COO of Rexahn. “We will continue to develop RX-3117, which has potential therapeutic applications in a broad range of cancers, including colon, lung and pancreatic cancer.”

In September 2009, Rexahn entered into a commercialization and development agreement with Teva Pharmaceutical Industries Limited for RX-3117. Under the agreement, Rexahn is eligible to receive development, regulatory and sales milestone payments, as well as royalties on net sales worldwide.

About RX-3117

RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that inhibits DNA methyltransferase, a cyclin-dependent kinase, and DNA synthesis. Potential indications of RX-3117 are solid tumors including colon, lung and pancreatic cancers. RX-3117 has demonstrated its ability to overcome cancer drug resistance in cancer cells, in particular, gemcitabine-resistance in the human lung cancer cell. The US and European patent issued for RX-3117 claims composition of matter, synthesis and methods (2008 and 2010, respectively).

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™, and a robust pipeline of preclinical compounds to treat multiple cancers and CNS disorders. Rexahn also operates key R&D programs of nano-medicines, 3D-GOLD, and TIMES drug discovery platforms. For more information, please visit www.rexahn.com.

Safe Harbor

To the extent any statements made in this press release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about Rexahn’s plans, objectives, expectations and intentions with respect to future operations and products and other statements identified by words such as “will,” “potential,” “could,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause Rexahn’s actual results to be materially different than those expressed in or implied by Rexahn’s forward-looking statements. For Rexahn, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of Rexahn’s licensees or sublicensees; the success of clinical testing; and Rexahn’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect Rexahn’s actual results are described in Rexahn’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. Rexahn undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Mad Catz (MCZ) Signs Licensing Agreement with Sony Computer Entertainment Japan

Mad Catz Interactive, Inc. (“Mad Catz”) (AMEX/TSX: MCZ) announced today that it has entered into a PlayStation_® Accessory Licensing Agreement with SCEJ (Sony Computer Entertainment Japan), a division of Sony Computer Entertainment Inc.

The agreement permits Mad Catz to manufacture and distribute products designed for use with the PlayStation_®3 computer entertainment system and the PlayStation_®Vita portable entertainment system throughout Japan.

“Since we announced the opening of our sales and marketing office in Japan, we have moved rapidly to build brand awareness, localize products and partner with Japanese publishers and developers,” said Darren Richardson, the President and Chief Executive Officer of Mad Catz Interactive, Inc. “Securing a Licensing Agreement with SCEJ is an important step in growing our distribution footprint as we continue our pursuit of growing our international business.”

The first licensed products released throughout Japan as part of the agreement was a selection of licensed PlayStation_®Vita accessories, now shipping throughout the region.

PlayStation is a registered trademark of Sony Computer Entertainment Inc.

About Mad Catz

Mad Catz Interactive, Inc. (AMEX/TSX: MCZ) is a global provider of innovative interactive entertainment products marketed primarily under its Mad Catz^® (casual gaming), Cyborg™ (pro gaming), Tritton^® (gaming audio), Saitek^® (simulation), and Eclipse™ (home and office) brands. Mad Catz also develops flight simulation software through its internal ThunderHawk Studios™; operates flight simulation centers under its Saitek brand; operates a videogame content website under its GameShark^® brand; publishes games under its Mad Catz brand; and distributes games and videogame products for third parties. Mad Catz distributes its products through most leading retailers offering interactive entertainment products and has offices in North America, Europe and Asia. For additional information please go to www.madcatz.com.

Social Media

Facebook: http://www.facebook.com/MadCatzInc

Twitter: http://twitter.com/MadCatzInc

YouTube: http://www.youtube.com/MadCatzCompany

Safe Harbor

This press release contains forward-looking statements about the Company’s business prospects that involve substantial risks and uncertainties. The Company assumes no obligation to update the forward-looking statements contained in this press release as a result of new information or future events or developments. You can identify these statements by the fact that they use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “should,” “plan,” “goal,” “believe,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Among the factors that could cause actual results to differ materially are the following: the ability to maintain or renew the Company’s licenses; competitive developments affecting the Company’s current products; first party price reductions; the ability to successfully market both new and existing products domestically and internationally; difficulties or delays in manufacturing; or a downturn in the market or industry. A further list and description of these risks, uncertainties and other matters can be found in the Company’s reports filed with the Securities and Exchange Commission and the Canadian Securities Administrators.

Openwave (OPWV) Announces Pursuit of Strategic Alternatives for Products Business

Openwave Systems Inc. (Nasdaq: OPWV), a global software innovator and the inventor of the mobile internet, announced today that its Board of Directors has determined to pursue strategic alternatives for the company’s mediation and messaging products business. The pursuit of strategic alternatives is designed to focus the company on its intellectual property initiative and drive long-term profitability. Openwave has retained Jefferies & Company, Inc. as its exclusive financial advisor in connection with its strategic review.

“We have made significant investments in our products over the past several years. We believe our strategy will enable us to derive the maximum value from our innovative and market-leading messaging and mediation product lines for both our shareholders and our customers,” said Mike Mulica, CEO of Openwave. “Moving forward, we are focusing our efforts on a multi-pronged strategy to realize the value of Openwave’s patents that are foundational to the mobile internet.”

Openwave will make further information available as, and when, a specific transaction or transactions occur.

About Openwave

Openwave Systems Inc. (Nasdaq: OPWV) is a global software innovator and the inventor of the mobile internet. Openwave established many of the foundational patents that allow mobile devices to connect to the Internet. Over the years, the company has built a patent portfolio of approximately 200 patents covering many innovations spanning smart devices, cloud technologies and unified messaging. Today Openwave provides all-Internet Protocol (all-IP) mediation and messaging solutions that enable communication service providers to create and deliver smarter services.

Building on its mobile data heritage, Openwave mobilizes the Internet with data-driven solutions that comprehensively enhance IP traffic and increase the value of the mobile network. Openwave arms its customers with a 360-degree view of network activity plus the tools to help them proactively optimize network resources (Congestion Control), react to user behavior with smarter data plans and services (Price Plan Innovation), and deliver a contextually relevant messaging experience (Converged Messaging).

Openwave is a global company with a blue chip customer base spanning North America, Latin America, Australia and New Zealand, Asia, Africa, Europe, and the Middle East. It holds Openwave is headquartered in Silicon Valley, California.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding Openwave’s expectations regarding its future strategic direction. All statements other than statements of historical fact contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only current predictions and are subject to known and unknown risks, uncertainties and other factors that may cause Openwave’s actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements. These forward-looking statements are subject to a number of risks, including the ability of Openwave to realize anticipated results of its strategy, the ability of Openwave to deliver and capitalize on the opportunities of its strategy, the ability of Openwave to execute its strategy as well as those risk factors discussed in filings with the U.S. Securities and Exchange Commission (“SEC”), including but not limited to the Company’s Annual Report on Form 10-K filed on September 6, 2011, and any subsequently filed reports on Forms 10-Q and 8-K. Openwave undertakes no duty to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Broadwind Energy (BWEN) Wins $23 Million Tower Order

Broadwind Energy, Inc. (NASDAQ: BWEN) today announced strong fourth-quarter orders, including a $23 million order for wind turbine towers. The tower order was Broadwind’s first order from a leading U.S. wind turbine manufacturer and will encompass towers for various domestic wind projects. The towers will be produced in Broadwind’s Manitowoc, Wisconsin facility for delivery during the second half of 2012.

President & CEO Peter Duprey stated, “Fourth-quarter orders were strong across each of our business segments including gearing, towers and services. We are well positioned for revenue growth in 2012. We are delighted to win our first tower order with a major new customer—this fits with our strategy to further diversify our customer base.”

About Broadwind Energy, Inc.

Broadwind Energy (NASDAQ: BWEN) applies decades of deep industrial expertise to innovate integrated solutions for customers in the energy and infrastructure markets. From gears and gearing systems for wind, oil and gas and mining applications to wind towers, to comprehensive remanufacturing of gearboxes and blades, to operations and maintenance services, and specialty weldments, we have solutions for the energy needs of the future. With facilities throughout the U.S., Broadwind Energy’s talented team of 800 employees is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Find out more at www.bwen.com.

Forward-Looking Statements

This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995—that is, statements related to future, not past, events. Forward-looking statements are based on current expectations and include any statement that does not directly relate to a current or historical fact. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “anticipate,” “believe,” “intend,” “expect,” “plan,” “will” or other similar words. These forward-looking statements involve certain risks and uncertainties that ultimately may not prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. The Company’s forward looking statements may include or relate to the Company’s plans to grow its business and its expectations regarding its operations, revenue growth and the business of its customers; the Company’s expectations regarding its plan to restructure its operations by consolidating its operations; the sufficiency of the Company’s working capital; and the Company’s expectations regarding the state of the wind energy market generally, as well as the Company’s expectations relating to the economic downturn and the potential impact on its business and the business of its customers. For further discussion of risks and uncertainties, individuals should refer to the Company’s SEC filings. The Company undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this news release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. All forward-looking statements are qualified in their entirety by this cautionary statement.

China GrenTech (GRRF) Enters Into Definitive Agreement With Talenthome Management Ltd. and Xing Sheng Corp. Ltd.

SHENZHEN, China, Jan. 12, 2012 /PRNewswire-Asia-FirstCall/ — China GrenTech Corporation Limited (NASDAQ: GRRF, “GrenTech,” or the “Company”), a leading China-based provider of radio frequency and wireless coverage products and services, today announced that it has entered into an agreement and plan of merger (the “Merger Agreement”) with Talenthome Management Limited (“Parent”), a British Virgin Islands exempted company, and Xing Sheng Corporation Limited (“Merger Sub”), a Cayman Islands exempted company wholly-owned by Parent. Parent is jointly owned indirectly by Mr. Yingjie Gao, the Company’s Chairman and Chief Executive Officer, Ms. Rong Yu, the Company’s Director and Chief Financial Officer, and Ms. Yin Huang (together, the “Buyer Group”). The Buyer Group collectively beneficially owns approximately 41.9% of the Company’s issued and outstanding ordinary shares and intends to finance the merger and the other transactions contemplated by the Merger Agreement through proceeds from a loan facility in the amount of HK$320,000,000 from Guotai Junan Finance (Hong Kong) Limited.

Pursuant to the Merger Agreement, (i) upon the terms and subject to the conditions set forth therein, at the effective time of the merger, Merger Sub will be merged with and into the Company and the Company will become a wholly-owned subsidiary of Parent, and (ii) each ordinary share of the Company (including ordinary shares represented by American Depositary Shares (“ADSs”), each of which represents 25 ordinary shares) issued and outstanding immediately prior to the effective time of the merger will be cancelled in exchange for the right to receive US$0.126 (or US$3.15 per ADS) in cash without interest, except for the ordinary shares (including ordinary shares represented by ADSs) (x) beneficially owned by the Buyer Group, which will be cancelled without receiving any consideration, and (y) owned by holders of such ordinary shares who have validly exercised and not effectively withdrawn or lost their appraisal rights pursuant to Section 238 of the Cayman Islands Companies Law, as amended. This represents a 23.0% premium over the closing price as quoted by Bloomberg L.P. on November 11, 2011 and a 40.6% over the 60-trading day volume weighted average price as quoted by Bloomberg L.P. on November 11, 2011, the last trading day prior to the Company’s announcement on November 14, 2011 that it had received a “going private” proposal.

The Company’s Board of Directors, acting upon the unanimous recommendation of the Independent Committee formed by the Board of Directors, approved the Merger Agreement and the merger contemplated in the Merger Agreement and resolved to recommend that the Company’s shareholders vote to approve and adopt the Merger Agreement and the merger. The Independent Committee, which is composed solely of directors unrelated to Parent, Merger Sub or any of the management members of the Company, negotiated the terms of the Merger Agreement with the assistance of its financial and legal advisors.

The merger contemplated in the Merger Agreement, which is currently expected to close before the end of the second quarter of 2012, is subject to the approval by an affirmative vote of shareholders representing two-thirds or more of the ordinary shares present and voting in person or by proxy at a meeting of the Company’s shareholders which will be convened to consider the approval and adoption of the Merger Agreement and the merger, as well as certain other customary closing conditions. The Buyer Group has agreed to vote to approve the Merger Agreement and the merger. If completed, the merger will result in the Company becoming a privately-held company and its ADSs would no longer be listed on the NASDAQ Global Select Market.

William Blair & Company, L.L.C. is serving as financial advisor to the Independent Committee. Cleary Gottlieb Steen & Hamilton LLP is serving as United States legal advisor to the Independent Committee and Conyers Dill & Pearman is serving as Cayman Islands legal advisor to the Independent Committee. Ropes & Gray LLP is serving as United States legal advisor to the Company. Skadden, Arps, Slate, Meagher & Flom LLP is serving as United States legal advisor to the Buyer Group. McDermott Will & Emery LLP is serving as United States legal advisor to William Blair & Company, L.L.C.

Additional Information about the Transaction
The Company will furnish to the Securities and Exchange Commission (the “SEC”) a report on Form 6-K regarding the proposed merger, which will include the Merger Agreement and related documents. All parties desiring details regarding the proposed merger are urged to review these documents, which are available at the SEC’s website (http://www.sec.gov).

In connection with the proposed merger, the Company will prepare and mail a proxy statement to its shareholders. In addition, certain participants in the proposed merger will prepare and mail to the Company’s shareholders a Schedule 13E-3 transaction statement. These documents will be filed with or furnished to the SEC. INVESTORS AND SHAREHOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THESE MATERIALS AND OTHER MATERIALS FILED WITH OR FURNISHED TO THE SEC WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE PROPOSED MERGER AND RELATED MATTERS. In addition to receiving the proxy statement and Schedule 13E-3 transaction statement by mail, shareholders also will be able to obtain these documents, as well as other filings containing information about the Company, the proposed merger and related matters, without charge, from the SEC’s website (http://www.sec.gov) or at the SEC’s public reference room at 100 F Street, NE, Room 1580, Washington, D.C. 20549. In addition, these documents can be obtained, without charge, by contacting the Company at the following address and/or phone number:

China GrenTech Corporation Limited
15th Floor, Block A, Guoren Building
Keji Central 3rd Road
Hi-Tech Park, Nanshan District
Shanghai 518057, People’s Republic of China
Telephone: (86 755) 2650-3007

The Company and certain of its directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be “participants” in the solicitation of proxies from our shareholders with respect to the proposed merger. Information regarding the persons who may be considered “participants” in the solicitation of proxies will be set forth in the proxy statement and Schedule 13E-3 transaction statement relating to the proposed merger when it is filed with the SEC. Additional information regarding the interests of such potential participants will be included in the proxy statement and Schedule 13E-3 transaction statement and the other relevant documents filed with the SEC when they become available.

This announcement is neither a solicitation of proxy, an offer to purchase nor a solicitation of an offer to sell any securities and it is not a substitute for any proxy statement or other filings that may be made with the SEC should the proposed merger proceed.

About China GrenTech
GrenTech is a leading developer of radio frequency (“RF”) technology in China and a leading provider of wireless coverage products and services in China. The Company uses RF technology to design and manufacture wireless coverage products, which enables telecommunications operators to expand the reach of their wireless communication networks to indoor and outdoor areas such as buildings, highways, subways, tunnels and remote regions. China GrenTech’s wireless coverage services include design, installation and project warranty services. The Company also tailors the design and configuration of its wireless coverage products to the specific requirements of its customers.

Based on its in-house RF technology platform, the Company also develops and produces base station RF parts and components sold to base station manufacturers. GrenTech is a qualified supplier of RF parts and components to major global and domestic base station manufacturers. For more information, please visit www.GrenTech.com.cn.

Safe Harbor Statement
Certain statements contained in this announcement may be viewed as “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of GrenTech to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. The accuracy of these statements may be impacted by a number of business risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, and other risks outlined in GrenTech’s filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1 and annual reports on Form 20-F. GrenTech undertakes no ongoing obligation, other than that imposed by law, to update these statements.

Quest (QRM) Reports Strong Summer Program Drill Results at Strange Lake, Intersects 144.4 Metres at 1.44% TREO

TORONTO, ONTARIO — (Marketwire) — 01/12/12 — Quest Rare Minerals Ltd. (TSX VENTURE:QRM)(NYSE Amex:QRM) is pleased to report the assay results from the 2011 definition diamond drilling program completed on its Strange Lake B-Zone Rare Earth Element (REE) deposit. Final lab results for holes BZ-11-118 to BZ-11-255 have returned multiple, high-grade Total Rare Earth Oxide (TREO) intersections of between 1.12% and 6.11% over thicknesses of 2.34 m to 147.0 m. Heavy Rare Earth Oxide (HREO) represents between 22.4% and 76.5% of the TREO content intersected in the new drilling. Best intersection grades returned 1.44% TREO over 144.4 m (BZ11218); 1.23% TREO over 116.1 m (BZ11189), including 3.04% TREO over 11.7 m and 4.9% TREO over 4.9 m; and 1.18% TREO over 95.9 m (BZ11135), including 1.48% TREO over 45.6 m and 3.29% TREO over 9.9 m. Important enrichment in zirconium (ZrO2), niobium (Nb2O5) and hafnium (HfO2) continues to characterize mineralization. The detailed drill sample analysis table and typical diamond drill sections are available on Quest’s website homepage at www.questrareminerals.com.

“Our 2011 definition program has now provided Quest with the confidence of good continuity and grade of the B-Zone deposit within the pit shell outline established by our April 2011 Revised Resource Estimate,” said Peter Cashin, Quest’s President & CEO. “Our exploration efforts will now focus on upgrading our Indicated and Inferred Resource into Proven and Probable Reserves, to be used in the pre-feasibility study now underway for the B-Zone. We have now defined sufficient resources to more than satisfy the minimum 25-year production model established by the Preliminary Economic Assessment report delivered in 2010. Geotechnical and metallurgical drilling in support of our pre-feasibility study was also completed during the 2011 field season.”

B-Zone Definition Drill Program

Assays have been received for 138 diamond drill holes representing 17,110.4 m (see Table 1). The drilling program tested the extent of B-Zone mineralization to the limits of the Whittle Pit shell established by Quest’s 43-101 Revised Resource Estimate (see Press Release : April 13, 2011), on a 50 m by 50 m drilling pattern (see Figure 1). The new drilling was focused on tight definition of the upper 150 m of the deposit, although mineralization is observed to continue down to 325 m vertical. In addition to enlarging the peripheral limits to the deposit within the pit shell, drilling indicates that good higher-grade Pegmatite-style mineralization continues to the southwest, past the established limit to the pit shell (see Figure 2). In addition to the definition drilling, 53 holes for 4,772.0 m were completed for metallurgical testing purposes across the full extent of mineralization defined within the pit shell as well as for geotechnical testing. This data will be used in the pre-feasibility study currently underway on the B-Zone.

The best results from the definition drill program (see Table 1 for drillhole locations) are:

----------------------------------------------------------------------------
                                 Length                                    %
HOLE-ID           FROM      TO      (m)   TREO%   LREO%   HREO%  (HREO/TREO)
----------------------------------------------------------------------------
BZ11118          12.86   54.47    41.61  1.6260  0.8491  0.7769        47.78
----------------------------------------------------------------------------
including        18.30   30.57    12.27  2.3812  1.1662  1.2150        51.03
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11122           9.00  115.19   106.19  1.1078  0.6264  0.4814        43.46
----------------------------------------------------------------------------
including        27.18   44.00    16.82  1.7909  0.7524  1.0387        58.00
----------------------------------------------------------------------------
and including    27.18   34.90     7.72  2.7055  1.0407  1.6649        61.54
----------------------------------------------------------------------------
and including    84.41   96.10    11.69  1.3249  0.7121  0.6130        46.27
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11124          16.80   72.40    55.60  1.1349  0.6233  0.5115        45.07
----------------------------------------------------------------------------
including        16.80   32.50    15.70  1.4139  0.8132  0.6007        42.48
----------------------------------------------------------------------------
and including    69.18   72.40     3.22  2.4528  1.1808  1.2714        51.83
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11125           2.82  126.00   123.18  1.1257  0.5773  0.5484        48.72
----------------------------------------------------------------------------
including        19.80   37.25    17.45  2.5327  0.8238  1.7088        67.47
----------------------------------------------------------------------------
and including    27.60   35.25     7.65  3.6087  0.9373  2.6714        74.03
----------------------------------------------------------------------------
and including    79.94   97.50    17.56  1.0490  0.6454  0.4036        38.47
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11126           3.00  126.00   123.00  1.0726  0.5951  0.4773        44.50
----------------------------------------------------------------------------
including        31.00   60.64    29.64  1.8610  0.9088  0.9522        51.16
----------------------------------------------------------------------------
and including    31.00   39.71     8.71  2.4447  1.0988  1.3456        55.04
----------------------------------------------------------------------------
and including    50.46   55.36     4.90  3.6769  1.8551  1.8218        49.55
----------------------------------------------------------------------------
and including    50.46   60.64    10.18  2.3681  1.2265  1.1416        48.21
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11135           1.25   97.00    95.75  1.1843  0.6218  0.5626        47.50
----------------------------------------------------------------------------
including         4.75   50.36    45.61  1.4832  0.6760  0.8073        54.43
----------------------------------------------------------------------------
and including    40.50   50.36     9.86  3.2870  1.0947  2.1922        66.69
----------------------------------------------------------------------------
and including     4.75    6.58     1.83  3.3806  1.6622  1.7179        50.82
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11138           2.30  126.00   123.70  1.0830  0.6115  0.4717        43.55
----------------------------------------------------------------------------
including         2.30   45.00    42.70  1.3366  0.7258  0.6109        45.70
----------------------------------------------------------------------------
and including     6.73   17.34    10.61  1.5308  0.7573  0.7734        50.52
----------------------------------------------------------------------------
and including    27.86   36.00     8.14  1.6422  0.9113  0.7310        44.51
----------------------------------------------------------------------------
and including    92.00  109.64    17.64  1.2895  0.7180  0.5715        44.32
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11141           3.77  126.00   122.23  1.1390  0.6134  0.5256        46.14
----------------------------------------------------------------------------
including         3.77   47.36    43.59  1.5088  0.6900  0.8188        54.27
----------------------------------------------------------------------------
and including     9.33   27.00    17.67  1.8384  0.8029  1.0356        56.33
----------------------------------------------------------------------------
and including    20.31   27.00     6.69  2.2973  0.9061  1.3910        60.55
----------------------------------------------------------------------------
and including    44.00   47.36     3.36  3.2102  1.1954  2.0148        62.76
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11143           1.69  126.00   124.31  1.1291  0.6668  0.4623        40.94
----------------------------------------------------------------------------
including        46.87   64.00    17.13  2.7298  1.5151  1.2148        44.50
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11150           9.20  111.00   101.80  1.0993  0.6641  0.4352        39.59
----------------------------------------------------------------------------
including        45.94   59.25    13.31  1.9343  0.9742  0.9600        49.63
----------------------------------------------------------------------------
and including    53.89   59.25     5.36  2.1683  0.8414  1.3270        61.20
----------------------------------------------------------------------------
and including    75.50   81.68     6.18  1.4024  0.8750  0.5278        37.64
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11164           6.00  126.00   120.00  1.0924  0.5848  0.5076        46.47
----------------------------------------------------------------------------
including        23.90   73.65    49.75  1.4425  0.6794  0.7631        52.90
----------------------------------------------------------------------------
and including    58.98   60.55     1.57  2.0250  1.1133  0.9118        45.02
----------------------------------------------------------------------------
and including    68.45   73.65     5.20  4.1464  1.4708  2.6756        64.53
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11176           6.49  150.00   143.51  1.0957  0.6054  0.4903        44.75
----------------------------------------------------------------------------
including        11.00   60.35    49.35  1.3325  0.6583  0.6741        50.59
----------------------------------------------------------------------------
and including    22.16   60.35    38.19  1.4486  0.6917  0.7570        52.25
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11189           9.90  126.00   116.10  1.2293  0.7328  0.4965        40.39
----------------------------------------------------------------------------
including        32.54   36.48     3.94  4.9015  2.3843  2.5172        51.36
----------------------------------------------------------------------------
and including    76.66   88.34    11.68  3.0352  1.5811  1.4541        47.91
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11218           5.65  150.00   144.35  1.1437  0.6226  0.5211        45.56
----------------------------------------------------------------------------
including        17.60   18.60     1.00  3.1681  2.4576  0.7105        22.43
----------------------------------------------------------------------------
and including    34.48   40.48     6.00  2.0526  0.7954  1.2572        61.25
----------------------------------------------------------------------------
and including   118.15  126.15     8.00  2.6715  1.2857  1.3858        51.87
----------------------------------------------------------------------------

BZ11228           3.30  126.00   122.70  1.1060  0.6576  0.4484        40.54
----------------------------------------------------------------------------
including         4.60   58.41    53.81  1.3265  0.7528  0.5737        43.25
----------------------------------------------------------------------------
and including    24.50   30.65     6.15  2.0825  1.2053  0.8772        42.12
----------------------------------------------------------------------------
and including    38.38   44.60     6.22  1.9376  0.9378  0.9998        51.60
----------------------------------------------------------------------------
Where: TREO=Total Rare Earth Oxides, includes Y2O3=yttrium oxide (i),
La2O3=lanthanum oxide (i), Ce2O3=cerium oxide (i), Pr2O3=praseodymium
oxide (i), Nd2O3=neodymium oxide (i), Sm2O3=samarium oxide,
Eu2O3=europium oxide, Gd2O3=gadolinium oxide, Tb2O3=terbium oxide (i),
Dy2O3=dysprosium oxide (i), Ho2O3=holmium oxide, Er2O3=erbium oxide,
Tm2O3=thulium oxide (i), Yb2O3=ytterbium oxide, Lu2O3=lutetium oxide
(i); LREO=light rare earth oxides, includes La2O3=lanthanum oxide,
Ce2O3=cerium oxide, Pr2O3=praseodymium oxide, Nd2O3=neodymium oxide,
Sm2O3=samarium oxide; HREO=heavy rare earth oxides, includes Y2O3=yttrium
oxide, Eu2O3=europium oxide, Gd2O3=gadolinium oxide, Tb2O3=terbium oxide,
Dy2O3=dysprosium oxide, Ho2O3=holmium oxide, Er2O3=erbium oxide,
Tm2O3=thulium oxide, Yb2O3=ytterbium oxide, Lu2O3=lutetium oxide. The
principal REO at the B-Zone are depicted by an asterisk (i).

The better grades of mineralization are associated with what is termed Pegmatite-style material, which is composed of a high proportion of pegmatite sheets that are intercalated with extremely-altered Strange Lake peralkaline granite at the uppermost parts of the B-Zone mineralized system. The highly-altered, granite-hosted zones continue to carry elevated grades of REE in excess of 0.7% TREO over core lengths of more than 314.6 m (see Press Release: December 9, 2010). These grades exceed the economic cut-off of 0.58% TREO determined for the deposit by Quest’s Revised Resource Estimate for the B-Zone (see Press Release: April 13, 2011).

2012 Exploration Program

Plans for upcoming winter and summer exploration programs on the B-Zone are well advanced and will include 15,000 m of exploration and geotechnical drilling, prospecting, geological mapping and rock sampling as well as the collection of additional bulk sample material to supplement an 18-tonne sample currently in storage. This material will be used for the planned Pilot Mill testing program to be undertaken once the metallurgical flow sheet for the B-Zone has been finalized. In addition, preliminary engineering and baseline environmental work for use in the current pre-feasibility study for the B-Zone will continue. As well, parallel-path data collection for use in the subsequent bankable feasibility study (BFS) of the B-Zone has been undertaken as a means to fast-track completion of the BFS. The exploration drilling will focus on defining additional areas of surface high grade Pegmatite-style mineralization on five priority targets located on the Strange Lake property.

Quality Control

Mr. Peter Cashin, P. Geo., is the qualified person on the Strange Lake Project under National Instrument 43-101 and is responsible for this news release. Material for analysis has been obtained from drill core which was cut in half using a diamond saw. Half of the core was sent to the lab for analysis, with the remaining half left on-site for future reference. A strict QA/QC program is followed which includes the use of elemental standards, duplicates and blanks. Analyses were performed by Activation Laboratory Limited of Ancaster, Ontario.

About Quest Rare Minerals

Quest Rare Minerals Ltd. is a Canadian-based exploration company focused on the identification and discovery of new and significant Rare Earth deposit opportunities. Quest is publicly listed on the TSX Venture Exchange and NYSE Amex as “QRM” and is led by a highly-respected management and technical team with a proven mine finding track record. Quest is currently advancing several high-potential projects in Canada’s premier exploration areas: the Strange Lake and Misery Lake areas of northeastern Quebec and the Plaster Rock area of northwestern New Brunswick. Quest’s 2009 exploration led to the discovery of a significant new Rare Earth metal deposit, the B-Zone, on its Strange Lake property in northeastern Quebec. Quest recently filed a 43-101 Indicated and Inferred Resource Estimate on the B-Zone deposit and has completed a Preliminary Economic Assessment (PEA) for the deposit. In addition, Quest announced the discovery of an important new area of REE mineralization on its Misery Lake project, approximately 120 km south of Strange Lake project. Quest continues to pursue high-value project opportunities throughout North America. As a result of a marketed equity financing completed in October 2010, Quest has a strong working capital position of $44.5 million. This will be sufficient to advance Quest’s plans of completing pre-feasibility and bankable feasibility studies of the B-Zone REE deposit and to continue exploration on its other rare earth properties.

Forward-Looking Statements

This news release contains statements that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities legislation. Forward-looking information and statements may include, among others, statements regarding the future plans, costs, objectives or performance of Quest Rare Minerals Ltd. (“Quest”), or the assumptions underlying any of the foregoing. In this news release, words such as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate” and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits that Quest will derive. Forward-looking statements and information are based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Quest’s control. These risks, uncertainties and assumptions include, but are not limited to, those described under “Risk Factors” in Quest’s annual information form dated March 2, 2011, and under the heading “Risk Factors” in Quest’s Management’s Discussion and Analysis for the quarter ended July 31, 2011, both of which are available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Quest does not intend, nor does Quest undertake any obligation, to update or revise any forward-looking information or statements contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws.

To view Figure 1 – Geological and Diamond Drilling Compilation Map, B-Zone REE Deposit, Strange Lake Project, Quebec, please visit the following link: http://media3.marketwire.com/docs/758047_fig_1.pdf

To view Figure 2 – Cumulative Thickness Isopach Map of Pegmatite-style Mineralization, B-Zone REE Deposit, Strange Lake, Quebec, please visit the following link: http://media3.marketwire.com/docs/758047_fig_2.pdf

 Table 1 - Summer Diamond Drillhole Location Table, B-Zone Deposit, Strange
                                Lake, Quebec
----------------------------------------------------------------------------

HOLE-ID       Easting   Northing  Elevation (m)    Length      Dip   Azimuth
----------------------------------------------------------------------------
BZ11118        427980    6243074            449    125.30   -90.00      0.00
BZ11119        428027    6243000            457    114.05   -90.00      0.00
BZ11120        428063    6242949            463    117.00   -90.00      0.00
BZ11121        428094    6242897            472    117.00   -90.00      0.00
BZ11122        427967    6243023            454    115.19   -90.00      0.00
BZ11123        427994    6242969            459    117.00   -90.00      0.00
BZ11124        428022    6242910            468    126.00   -90.00      0.00
BZ11125        428063    6242837            480    126.00   -90.00      0.00
BZ11126        428087    6242794            487    126.00   -90.00      0.00
BZ11127        428111    6242750            496    126.00   -90.00      0.00
BZ11128        428134    6242711            504    126.00   -90.00      0.00
BZ11129        428158    6242667            513    123.00   -90.00      0.00
BZ11130        428189    6242611            525    126.00   -90.00      0.00
BZ11131        428147    6242599            525     99.00   -90.00      0.00
BZ11132        428127    6242633            521    117.00   -90.00      0.00
BZ11133        428025    6242813            481     99.00   -90.00      0.00
BZ11134        427998    6242866            473    151.00   -90.00      0.00
BZ11135        428058    6242756            492     97.00   -90.00      0.00
BZ11136        427965    6242922            463    150.00   -90.00      0.00
BZ11137        427932    6242876            468    150.00   -90.00      0.00
BZ11138        427961    6242819            475    126.00   -90.00      0.00
BZ11139        428005    6242744            490    129.00   -90.00      0.00
BZ11140        427862    6242894            461    124.74   -65.00    150.00
BZ11141        427909    6242815            473    126.00   -90.00      0.00
BZ11142        427856    6243003            450    126.00   -90.00      0.00
BZ11143        428031    6242702            496    126.00   -90.00      0.00
BZ11144        427945    6242751            485    126.00   -90.00      0.00
BZ11145        427981    6242693            494    126.00   -90.00      0.00
BZ11146        428057    6242657            504    125.30   -90.00      0.00
BZ11147        427902    6242942            458    125.80   -65.00    150.00
BZ11148        428023    6242617            505    100.50   -90.00      0.00
BZ11149        428086    6242607            521    101.00   -90.00      0.00
BZ11150        428051    6243067            451    111.00   -90.00      0.00
BZ11151        428107    6242574            525     97.27   -90.00      0.00
BZ11152        428054    6242571            521     99.00   -90.00      0.00
BZ11153        427872    6242980            451    150.00   -65.00    150.00
BZ11154        428075    6242531            527     99.00   -90.00      0.00
BZ11155        428034    6242492            532    150.00   -90.00      0.00
BZ11156        427813    6242943            452    117.00   -65.00    150.00
BZ11157        427993    6242456            533    102.06   -90.00      0.00
BZ11158        428002    6242538            515    102.00   -90.00      0.00
BZ11159        428098    6243015            458    117.00   -90.00      0.00
BZ11160        427988    6242583            508    102.00   -90.00      0.00
BZ11161        428162    6242880            479     90.45   -90.00      0.00
BZ11162        427787    6242918            453    126.00   -65.00    150.00
BZ11163        428135    6242825            486    101.70   -90.00      0.00
BZ11164        427959    6242625            499    126.00   -90.00      0.00
BZ11165        428136    6243018            460    123.00   -90.00      0.00
BZ11166        427970    6242510            514    111.00   -90.00      0.00
BZ11167        427814    6242874            461    126.00   -90.00      0.00
BZ11168        428139    6243117            450    126.00   -65.00    150.00
BZ11169        428168    6242967            465    101.70   -90.00      0.00
BZ11170        427915    6242698            489    127.30   -90.00      0.00
BZ11171        427840    6242829            466    126.00   -65.00    150.00
BZ11172        428202    6242914            476    101.76   -90.00      0.00
BZ11173        427989    6242582            508     80.00   -90.00      0.00
BZ11174        428163    6243072            455    123.00   -90.00      0.00
BZ11175        427931    6242584            504    124.44   -90.00      0.00
BZ11176        427894    6242643            495    150.00   -90.00      0.00
BZ11177        428191    6243028            460    126.00   -90.00      0.00
BZ11178        428217    6242983            467     97.86   -90.00      0.00
BZ11179        428242    6242941            476     98.81   -90.00      0.00
BZ11180        427745    6242901            454    126.00   -65.00    150.00
BZ11181        428324    6242988            473    102.00   -90.00      0.00
BZ11182        428301    6243034            467     99.00   -90.00      0.00
BZ11183        427897    6242537            512    150.00   -90.00      0.00
BZ11184        428278    6243077            460    126.00   -90.00      0.00
BZ11185        427702    6242876            460    126.00   -65.00    150.00
BZ11186        428253    6243120            455    106.36   -90.00      0.00
BZ11187        427777    6242746            473    125.50   -90.00      0.00
BZ11188        427975    6242427            539    147.00   -90.00      0.00
BZ11189        428228    6243164            452    126.00   -90.00      0.00
BZ11190        428295    6243148            455    126.00   -90.00      0.00
BZ11191        427722    6242841            465    126.00   -65.00    125.80
BZ11192        428207    6243100            456    125.90   -90.00      0.00
BZ11193        428340    6243171            452    125.33   -90.00      0.00
BZ11194        427922    6242494            517    102.00   -90.00      0.00
BZ11195        427752    6242789            469    123.00   -90.00      0.00
BZ11196        428238    6243047            463    126.00   -90.00      0.00
BZ11197        428365    6243127            460    126.00   -90.00      0.00
BZ11198        427694    6242388            517    126.20   -90.00      0.00
BZ11199        427813    6242582            500    123.00   -90.00      0.00
BZ11200        427709    6242763            470    126.00   -65.00    150.00
BZ11201        427866    6242492            514    102.00   -90.00      0.00
BZ11203        427625    6242409            507    125.00   -90.00      0.00
BZ11204        427791    6242420            518    126.00   -90.00      0.00
BZ11205        427744    6242301            528    153.00   -90.00      0.00
BZ11206        427842    6242433            521    102.00   -90.00      0.00
BZ11207        427786    6242329            528    102.00   -90.00      0.00
BZ11208        428378    6242903            493     99.44   -90.00      0.00
BZ11209        427673    6242726            465    105.00   -65.00    150.00
BZ11210        427761    6242372            521    102.00   -90.00      0.00
BZ11211        427719    6242345            523    126.00   -90.00      0.00
BZ11212        427769    6242259            534    141.00   -90.00      0.00
BZ11213        427682    6242211            535    150.00   -90.00      0.00
BZ11214        427725    6242235            534    126.00   -90.00      0.00
BZ11215        427675    6242621            475    126.00   -65.00    150.00
BZ11216        427736    6242415            515    126.00   -90.00      0.00
BZ11217        427650    6242366            517    141.00   -90.00      0.00
BZ11218        427715    6242552            495    150.00   -65.00    150.00
BZ11219        427711    6242459            509    147.22   -90.00      0.00
BZ11220        427817    6242476            514    126.00   -90.00      0.00
BZ11221        427686    6242502            501    135.00   -90.00      0.00
BZ11222        427742    6242503            503    150.00   -65.00    150.00
BZ11223        427791    6242519            507    126.00   -90.00      0.00
BZ11224        427661    6242545            494    126.00   -90.00      0.00
BZ11225        427727    6242631            483    126.00   -90.00      0.00
BZ11226        427891    6242447            521    123.39   -90.00      0.00
BZ11227        427697    6242682            468    120.00   -65.00    150.00
BZ11228        427886    6242754            477    126.00   -90.00      0.00
BZ11229        427644    6242474            498    150.00   -65.00    150.00
BZ11230        428267    6242896            486    101.74   -90.00      0.00
BZ11231        427751    6242691            476    126.00   -65.00    150.00
BZ11232        428354    6242948            483    100.67   -90.00      0.00
BZ11233        428169    6242765            498    102.00   -90.00      0.00
BZ11234        427581    6242383            511    123.00   -90.00      0.00
BZ11235        427746    6242598            492    125.75   -90.00      0.00
BZ11236        428203    6242707            516     99.00   -90.00      0.00
BZ11237        428335    6243079            465    126.00   -90.00      0.00
BZ11238        427611    6242632            477    138.26   -90.00      0.00
BZ11239        428185    6242836            489    102.00   -90.00      0.00
BZ11240        427607    6242340            518    149.53   -90.00      0.00
BZ11241        428265    6243201            455    126.00   -65.00    330.00
BZ11242        427635    6242590            487    141.00   -90.00      0.00
BZ11243        427675    6242322            522    148.00   -90.00      0.00
BZ11244        427617    6242723            471    125.80   -65.00    150.00
BZ11245        427678    6242816            465    126.00   -90.00      0.00
BZ11246        427632    6242297            525    174.00   -90.00      0.00
BZ11248        427595    6242561            488    150.00   -65.00    150.00
BZ11249        427620    6242517            494    165.00   -65.00    150.00
BZ11250        427563    6242315            520    145.33   -90.00      0.00
BZ11251        427600    6242452            501    150.00   -90.00      0.00
BZ11252        427657    6242254            532    150.00   -90.00      0.00
BZ11253        427613    6242228            533    150.00   -90.00      0.00
BZ11254        427700    6242279            530    148.75   -90.00      0.00
BZ11255        427588    6242272            526    150.00   -90.00      0.00
                     ------------------------------------
                          TOTALS            138  17110.40
                     ------------------------------------

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Quest Rare Minerals Ltd.
Peter J. Cashin
President & CEO
(416) 916-0777 or Toll-Free: 1-877-916-0777
(416) 916-0779 (FAX)
info@questrareminerals.com
www.questrareminerals.com

SolarFocus (ENER) Launches UNI-SOLAR(R) Powered Kindle(TM) Cover at CES in Las Vegas

AUBURN HILLS, Mich., Jan. 12, 2012 (GLOBE NEWSWIRE) — United Solar, the global manufacturer of UNI-SOLAR® lightweight, flexible solar products and a wholly owned subsidiary of Energy Conversion Devices, Inc. (ECD) (Nasdaq:ENER) is proud to announce today the commercial launch of the world’s first solar-powered cover for the Amazon Kindle™ e-reader by SolarFocus Technology Co., Ltd., a leader in solar-powered portable products.

SolarFocus’ SolarKindle Lighted Cover uses UNI-SOLAR‘s proprietary technology to charge the Kindle’s internal battery as well as the cover’s integrated reserve battery, which is used to power the LED reading light featured on the inside of the cover. The solar cells, located on the front of the leather cover, are charged from direct exposure to the sun, providing unlimited extended power to the device.

The SolarKindle Lighted Cover will be revealed at the International Consumer Electronics Show (CES) this week (January 10-13, 2012) in Las Vegas, Nevada. The lightweight solar cover will be recognized as a 2012 Innovations Honoree in the Eco-Design and Sustainability Technologies category. The CES is hosted by the Consumer Electronics Association (CEA) and showcases the ground-breaking products and technologies influencing consumer technology.

“The SolarKindle Lighted Cover is a great example of the success of United Solar’s Open Solar™ initiative, which allows our strategic partner, SolarFocus, to leverage the differentiation of our unique high-performance, lightweight and flexible solar cells,” said Chris Bala, Vice President of Sales-Open Solar. “This innovative product represents just how easily UNI-SOLAR technology can be integrated seamlessly and cost effectively into everyday applications.”

The SolarKindle Lighted Cover is available on the web at SolarFocus’ webstore, solarmio.com, and at amazon.com. The product will be available through specialty retail outlets in the U.S., Canada and Europe in 2012.

United Solar, with more than 25 years experience in the solar industry, is the largest manufacturer of light weight, flexible solar panels in the world, and has been awarded nearly 70 United States patents for various technological advancements. For more information about the Open Solar initiative, please contact opensolar@uni-solar.com.

About United Solar/UNI-SOLAR®

United Solar has been a global leader in building-integrated and rooftop photovoltaics for over 25 years. The company manufactures, sells and installs thin-film solar laminates that convert sunlight into clean, renewable energy using proprietary technology for which the company has been awarded over 70 U.S. patents. UNI-SOLAR® brand products are unique because of their flexibility, light weight, ease of installation, durability, and real-world energy production. The company also designs, manufactures and installs rooftop photovoltaic systems, which enable customers to transform unused rooftop space into a value-generating asset. With the Open Solar™ initiative the company is seeking to build a community of solar innovators who will commercialize new products using the underlying, patented UNI-SOLAR technology. For more information on United Solar visit uni-solar.com or follow UNI-SOLAR on Facebook.com/unisolar and Twitter.com/uni_solar.

About SolarFocus Technology Co., Ltd.

Since 2005, SolarFocus has been at the forefront of the renewable energy revolution by providing competitively priced, energy saving and environmental-friendly solar powered products to both industry and consumers. As an industry leader in solar research and innovative product development, SolarFocus holds several solar technology patents with their products routinely used in such extreme environments as the Himalayas and the North Pole. For further information on SolarFocus products, please visit www.solarmio.com.

CONTACT: United Solar Contact:
         Kim Paulson
         Corporate Marketing Manager
         pr@uni-solar.com
         +1 (248) 299-6081

         SolarFocus Contact:
         Amy Chueh
         Sales Manager
         pr@solarmio.com
         +866-6615-8625

MGT Capital Investments (MGT) Names Robert Ladd as President and Chief Executive Officer

MGT Capital Investments, Inc. (“MGT,” “We,” or “the Company”) (AMEX: MGT – News), a holding company with operations in the healthcare industry, today announced that Robert Ladd has been named President and Chief Executive Officer, effective January 9, 2012. Mr. Ladd had previously served as interim President and Chief Executive Officer of the Company.

“We believe that we have made significant progress in 2011 by simplifying and rationalizing MGT and its subsidiaries. With consolidated cash of approximately $3.7 million at year-end 2011, and no debt, we believe that the Company is well-positioned to implement the necessary acquisition and divestiture strategies to support growth and investment returns for our shareholders. As the largest stockholder of MGT, I am excited to lead this transformation,” stated Robert Ladd, President and Chief Executive Officer.

About MGT Capital Investments, Inc.

MGT is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our subsidiary, Medicsight Ltd, including its wholly owned subsidiaries.

Medicsight is a medical technology company with operations in medical imaging software development and medical hardware devices. The company provides a computer-aided detection software application that is used to assist radiologists with early detection and measurement of colorectal polyps. The Company’s software received a CE Mark in 2009, as well as clearance from the U. S. FDA in May 2011. Medicsight has also developed an automated carbon dioxide medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized in partnership with a global distributor.

Forward Looking Statements

This press release contains forward-looking statements. The words or phrases “would be,” “will allow,” “intends to,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” or similar expressions are intended to identify “forward-looking statements.” MGT’s financial and operational results reflected above should not be construed by any means as representative of the current or future value of its common stock. All information set forth in this news release, except historical and factual information, represents forward-looking statements. This includes all statements about the Company’s plans, beliefs, estimates and expectations. These statements are based on current estimates and projections, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include issues related to: rapidly changing technology and evolving standards in the industries in which the Company and its subsidiaries operate; the ability to obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new business, license and sign new agreements; the unpredictable nature of consumer preferences; and other factors set forth in the Company’s most recently filed annual report and registration statement. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risks and uncertainties described in other documents that the Company files from time to time with the U.S. Securities and Exchange Commission.

China Shen Zhou Mining & Resources (SHZ) Enters into Memorandum of Understanding

BEIJING, Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ — China Shen Zhou Mining & Resources, Inc. (NYSE AMEX: SHZ), (“China Shen Zhou” or the “Company”), a Company engaged in the exploration, development, mining and processing of fluorite, zinc, lead, copper, and other nonferrous metals in China, today announced that the Company signed a Memorandum of Understanding to merge and acquire a number of fluorite and barite mining and mineral processing companies located in the Wuling mountains in the province of Guizhou. Negotiations are expected to be finalized within the next 60 days.

Since 2010, the Chinese government has issued a number of policies designed to raise the barriers to entry for the fluorite mining industry and to encourage fluorite mining companies to merge and integrate. China Shen Zhou, as the largest fluorite mining and mineral processing company in northern China, views the acquisition and integration of high-quality fluorite resources as a key part of the Company’s strategic plan.

Since the Company acquired 55% of Xinyi Mining Company in Anhui province, China Shen Zhou has considered acquiring a number of fluorite and barite rich mining companies located in southwestern China. As a result, China Shen Zhou identified and finished its due diligence on several targeted companies and the parties have reached an initial agreement regarding purchase price and transaction structure. Additional details concerning the acquisitions will be disclosed once the definitive agreements are executed.

Ms. Xiaojing Yu, the CEO of the China Shen Zhou, commented: “The Company has always believed that fluorite, as a widely used yet scarce strategic resource, will be in high demand given continuing economic development in China. China’s Wuling mountains are very rich in resources of fluorite and barite and possess excellent ore quality with low levels of phosphorus and sulfur. Barite is similar to fluorite as it is also a widely used diminishing resource.

“Because of China Shen Zhou’s advanced knowledge of the methods of separation of fluorite and barite ore and of methods of deep-processing of barite, the acquisitions of the Wuling mountain fluorite and barite resources will greatly enhance the Company’s reserves, laying the foundation for China Shen Zhou to become one of the largest fluorite mining and processing companies in China. Meanwhile, we will use the acquired barite resources to greatly improve the Company’s mining, processing and production capabilities.

“Furthermore, China Shen Zhou plans to work with local governments as well as both upstream and downstream enterprises to build a high-quality processing center and chemical industrial base to produce low-phosphorus and low-sulfur fluorite.”

Barite

Barite is a mineral consisting of barium sulfate, with a chemical composition of BaSO4, and is the largest natural mineral containing barium. Also, it is the largest source of barium. China is rich in barite, with barite reserves and production ranked the first in the world. Barite mines in China are mostly located in Guizhou province, which contains 34% of the total barite reserves in China.

Barite powder, the primary product of barite, is mainly used in the oil and gas industry as a weighting agent. Deep-processed precipitated barium sulfate, the raw material for making barium salts, is widely used in coatings, paints, inks, daily chemical products, textiles, papers and other products. Barite is categorized as a protective, non-metallic mining mineral by the Chinese Ministry of Land.

About China Shen Zhou Mining & Resources, Inc.

China Shen Zhou Mining & Resources, Inc., through its subsidiaries, is engaged in the exploration, development, mining, and processing of fluorite and nonferrous metals such as zinc, lead and copper in China. The Company has the following principal areas of interest in China: (a) fluorite extraction and processing in the Sumochaganaobao region of Inner Mongolia; (b) fluorite extraction and processing in Jingde County, Anhui Province; (c) zinc/copper/lead processing in Wulatehouqi of Inner Mongolia; and (d) zinc/copper exploration, mining and processing in Xinjiang.

For more information, please visit http://www.chinaszmg.com/.

Safe Harbor Statement

This press release may include certain statements that are not descriptions of historical facts, but are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology such as “will”, “believes”, “expects” or similar expressions. These forward-looking statements may also include statements about our proposed discussions related to our business or growth strategy, which is subject to change. Such information is based upon expectations of our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to uncertainties and contingencies beyond our control and upon assumptions with respect to future business decisions, which are subject to change. We do not undertake to update the forward-looking statements contained in this press release. For a description of the risks and uncertainties that may cause actual results to differ from the forward-looking statements contained in this press release, see our most recent Annual Report filed with the Securities and Exchange Commission (SEC) on Form 10-K, and our subsequent SEC filings. Copies of filings made with the SEC are available through the SEC’s electronic data gathering analysis retrieval system (EDGAR) at http://www.sec.gov.

Sprint Selects Mobile Network Director from Smith Micro Software (SMSI) to Help Optimize Network Experience for Users

Smith Micro Software, Inc. (NASDAQ: SMSI), a leading provider of wireless and mobility solutions, today announced that Sprint has selected Mobile Network Director™ to provide traffic management between networks (3G/4G /WiFi) while maintaining a high-quality experience for its subscribers.

Mobile Network Director helps Sprint meet today’s unprecedented growth in mobile data services. The precise, intelligent device controls provided by the solution can selectively manage data traffic in targeted locations during peak traffic periods. Mobile Network Director provides Sprint the ability to adjust network selection on subscribers’ devices as they move between coverage areas, enabling automated and seamless transitions between networks. Battery life on devices is increased since Mobile Network Director can turn on and off device radios as needed.

“While the majority of mobile operators have switched smartphone users to tiered data plans, Sprint is committed to offering our customers the best unlimited data plan in the industry,” said Fared Adib, Vice President of Product Development for Sprint. “Our relationship with Smith Micro Software is instrumental in the execution of that strategy, helping us to optimize our network resources while ensuring the best possible user experience. We’re looking forward to rolling out Mobile Network Director.”

“Improving the customer experience is the motivating force behind Sprint’s choice of our new solution,” said William W. Smith, Jr., President and CEO at Smith Micro Software. “We are excited to provide Sprint with a solution that automatically selects the best network option for the customer. Mobile Network Director makes the use of WiFi much simpler, which is a great convenience for the customer at home and in office environments. Testing has proven that WiFi management can actually improve battery performance as well.”

Sprint conducted extensive end users trials to evaluate the impact of using Mobile Network Director with customers utilizing multiple networks. The analytics proved that Sprint could improve the customer’s network experience through this unique approach and the trial results have been very positive.

For more information about Mobile Network Director, please visit www.smithmicro.com.

About Smith Micro Software, Inc.:

Smith Micro Software, Inc. provides software solutions that simplify, secure and enhance the mobile experience. Our portfolio of products and services spans Connectivity Management and Communications solutions. Smith Micro’s solutions include client and server software applications used by the world’s leading wireless operators, device manufacturers and enterprises. For more information about Smith Micro Software (NASDAQ: SMSI), visit smithmicro.com.

Safe Harbor Statement:

This release contains forward-looking statements that involve risks and uncertainties, including without limitation forward-looking statements relating to the company’s quarterly revenues guidance, its financial prospects and other projections of its performance, the company’s ability to increase its business and the anticipated timing and financial performance of its new products and services and potential acquisitions. Among the important factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements are changes in demand for the company’s products from its customers and their end-users, new and changing technologies and mobile communications products, customer acceptance of those technologies and products, new and continuing adverse economic conditions, and the company’s ability to compete effectively with other software providers. These and other factors discussed in the company’s filings with the Securities and Exchange Commission, including its filings on Forms 10-K and 10-Q, could cause actual results to differ materially from those expressed or implied in any forward-looking statements. The forward-looking statements contained in this release are made on the basis of the views and assumptions of management regarding future events and business performance as of the date of this release, and the company does not undertake any obligation to update these statements to reflect events or circumstances occurring after the date of this release.

Smith Micro, Mobile Network Director, and the Smith Micro logo are registered trademarks or trademarks of Smith Micro Software, Inc. All other trademarks and product names are the property of their respective companies.